Table 1 The relationship between c-Met expression and clinical features of ESCC (according to H-score)
From: Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
N | H-score ≤ 20 | H-score > 20 | P | |
|---|---|---|---|---|
Sex | ||||
Male | 73 | 39 | 34 | 0.198 |
Female | 17 | 12 | 5 | |
Age | ||||
≤59 | 45 | 25 | 20 | 0.832 |
>59 | 45 | 26 | 19 | |
Tumor location | ||||
Upper thoracic | 6 | 4 | 2 | 0.489 |
Middle thoracic | 48 | 24 | 24 | |
Lower thoracic | 35 | 22 | 13 | |
Abdominal | 1 | 1 | 0 | |
Tumor differentiation | ||||
Poor | 31 | 16 | 15 | 0.769 |
Moderate | 46 | 27 | 19 | |
Well | 13 | 8 | 5 | |
Distant metastasis | ||||
Yes | 27 | 13 | 14 | 0.286 |
Liver | 14 | 8 | 6 | 0.969 |
Lung | 19 | 8 | 11 | 0.114 |
No | 64 | 38 | 25 | |
Lymph node invasion | ||||
Yes | 85 | 48 | 37 | 0.877 |
No | 5 | 3 | 2 | |